Clinically, Andy has a particular interest in canine mast cell tumours and leveraging sentinel lymph mapping to improve the accuracy of cancer staging. His research interests focus on the diagnostic, therapeutic and prognostic role of the oncobiome, particularly the intestinal microbiome. He is also interested in novel diagnostic and therapeutic strategies in veterinary cancer patients, particularly those where there is translational relevance.